eCOA

Cambridge Cognition's eCOA (Electronic Clinical Outcome Assessment) solution provides digital bespoke questionnaires and universally recognised clinical scales for use in drug development and academic research studies. The platform is designed to support teams collecting neurocognitive and clinical outcome data within tight deadlines, with Cambridge Cognition's expert teams handling configuration, study set up, data management, and clinical scale licensing.

The solution operates as a unified platform, available in multiple languages and across multiple devices. It supports both site-based and decentralised trials, including patient self-administration without rater presence, enabling data collection across geographically distributed sites and patient populations.

Data Capture and Scoring

• All responses are collected electronically and scored in near real-time.
• Data is uploaded to a secure database, providing immediate access following collection.
• The platform supports both online and offline electronic data capture, ensuring continuity regardless of connectivity.
• Automated and standardised administration reduces variability in how questionnaires and scales are delivered.

Study Set Up and Configuration

• Fast and reliable study set up is supported by Cambridge Cognition's expert teams.
• Questionnaires and scales are configured to the sponsor's specification.
• A wide range of questionnaires and scales is available, including bespoke instruments and universally recognised clinical scales.
• Outcome measures are configurable to meet individual study requirements.
• The team manages clinical scale licensing on behalf of the study.

Support and Compliance

• 24/7 clinical support and issue resolution is provided throughout the study.
• A full audit trail is maintained to support regulatory compliance requirements.
• The platform is designed to meet regulatory standards applicable to clinical trial data collection.

Cambridge Cognition's eCOA solution covers therapeutic areas including Alzheimer's disease, depression, schizophrenia, Parkinson's disease, ADHD, and others, and integrates within a broader platform that also includes digital cognitive assessments, voice-based tools, rater training, and quality assurance capabilities.